BCL2 and idiopathic pulmonary fibrosis: The observed increases in gene and protein expression are the same antiapoptotic BCL-2 family members targeted by ABT-263, providing rationale for the increased sensitivity of in vitro human and mouse fibrotic fibroblasts, and IPF-associated fibroblasts, in PCLS to ABT-263.